Status:

COMPLETED

RAD001 in Advanced Sarcoma

Lead Sponsor:

Asan Medical Center

Collaborating Sponsors:

Novartis

Conditions:

Soft Tissue Sarcomas

Bone Sarcomas

Eligibility:

All Genders

17+ years

Phase:

PHASE2

Brief Summary

This trial intends to test the efficacy and safety of RAD001 in patients with advanced sarcoma who failed to conventional chemotherapy.

Detailed Description

This multicenter, phase II trial evaluated the efficacy and safety of everolimus in patients with metastatic or recurrent bone and soft tissue sarcoma after failure of anthracycline and/or ifosfamide.

Eligibility Criteria

Inclusion

  • Patients with histologically confirmed metastatic, unresectable bone or soft tissue sarcomas who had past treatment with anthracycline and/or ifosfamide to which the disease was primarily refractory or progressed after initial response.
  • Any of above drugs is allowed to be used as adjuvant treatment.
  • Unidimensionally measurable disease
  • 3 or less than prior chemotherapies
  • Age 17 years old or older
  • ECOG performance status 2 or less, Life expectancy 6 month or less
  • Adequate bone marrow, liver, kidney, and cardiac function
  • Written informed consent

Exclusion

  • Pregnant or lactating patients
  • Patients with resectable metastasis
  • Patients with history of CNS metastasis
  • Gastrointestinal stromal tumors, chondrosarcoma, neuroblastoma
  • Hypersensitivity to the active substance, to other rapamycin derivatives, or to any of the excipients.
  • Any preexisting medical condition of sufficient severity to prevent full compliance with the study

Key Trial Info

Start Date :

April 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT01830153

Start Date

April 1 2010

Last Update

April 12 2013

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea, 463-707

2

Asan Medical Center, University of Ulsan College of Medicine

Seoul, N/A = Not Applicable, South Korea, 138-736

3

Yeongnam University College of Medicine

Daegu, South Korea

4

Chungnam National University Hospital

Daejeon, South Korea, 301-721

RAD001 in Advanced Sarcoma | DecenTrialz